Results 31 to 40 of about 3,364,808 (342)

Rol de la terapia farmacológica en los trastornos del espectro autista

open access: yesRevista Médica Clínica Las Condes, 2022
Resumen: Los trastornos del espectro autista (TEA) se definen por déficits significativos y persistentes en dos dominios principales: a) interacción y comunicación social y b) comportamientos restrictivos, repetitivos.
Elisa Reyes, Lorena Pizarro
doaj   +1 more source

Metoclopramide Neurological Side Effects Screening; A Pharmacovigilence Study in Romanian Community Pharmacies [PDF]

open access: yes, 2015
Background. Metoclopramide is a pharmacological agent frequently used in therapy against nausea and vomiting that can occur in indigestion, motion sickness, gastric ulcer, pyloric spasm and after surgery as a side effect of some anesthetics.
Junghină, Adrian   +4 more
core   +4 more sources

Patterns of management of patients with dual disorder (psychosis) in Italy: a survey of psychiatrists and other physicians focusing on clinical practice [PDF]

open access: yes, 2018
© 2018 Clerici, de Bartolomeis, De Filippis, Ducci, Maremmani, Martinotti and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Patients with severe psychotic disorders such as ...
Acquas   +39 more
core   +4 more sources

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. [PDF]

open access: yes, 2017
ObjectiveParkinson's disease psychosis (PDP) is a frequent complication of idiopathic Parkinson's disease (iPD) with significant impact on quality of life and association with poorer outcomes.
Bizzarri   +29 more
core   +2 more sources

Antipsychotic Response in the First Week Predicts Later Efficacy [PDF]

open access: yes, 2012
Background and Aims: Time of onset of antipsychotic action is still a debated matter. We aimed to replicate and extend previous findings that early response can predict subsequent non-response.
Andrisano, Costanza   +7 more
core   +1 more source

Control of seizures in a clozapine-treated schizophrenia patient, using valproate: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2019
Schizophrenia is characterized by an adverse clinical course and poor psychosocial functioning, and causes problems in the social-cognitive sphere.
Hamza Ayaydın, Şermin Bilgen Ulgar
doaj   +1 more source

Time perception and its neuropsychological correlates in patients with schizophrenia and in healthy volunteers [PDF]

open access: yes, 2009
Disordered time perception has been reported in schizophrenia. We investigated time perception dysfunction and its neuropsychological correlates in patients with schizophrenia.
Andreasen   +56 more
core   +1 more source

Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices [PDF]

open access: yes, 2014
A recurring, foundational issue for evidence-based regulation is deciding whether to extend governmental approval from an existing use with sufficient current evidence of safety and efficacy to a novel use for which such evidence is currently lacking ...
Abbott, Ryan, Ayres, Ian
core   +3 more sources

The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects [PDF]

open access: yes, 2015
Funded by: •GW Pharmaceuticals Acknowledgements: The authors wish to thank Mrs Lesley Stevenson for technical support and Dr John Raymond, Dr Keith Parker and Dr Ethan Russo for providing human 5-HT1A CHO cells.
Cascio, Maria Grazia   +4 more
core   +1 more source

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis

open access: yesSystematic Reviews, 2023
Background There is evidence that antipsychotic drugs differ in their effect on the cognitive symptoms of schizophrenia. So far, there is no comprehensive systematic review available that would enable providers and patients to make informed choices ...
Lena Feber   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy